By Bhanvi Satija and Patrick Wingrove (Reuters) -Eli Lilly on Thursday downplayed CVS Health (NYSE:CVS)’s decision to drop the company’s obesity drug Zepbound from some lists of medicines it covers for reimbursement, but shares of the drugmaker still fell roughly 10% on investor worries that the move could blunt its sales momentum. Lilly’s leading position in weight loss and diabetes treatme ...
(Reuters) -Energy contractor Quanta Services (NYSE:PWR) beat first-quarter profit estimates and raised its annual forecast on Thursday, aided by sustained strength in demand for its infrastructure services. The ongoing power grid modernization and electrification in the U.S. and construction of data centers due to the AI boom is helping infrastructure service providers. Quanta also stands to ben ...
Investing.com -- US Treasury Secretary Scott Bessent has stated that the US will likely revisit the purchase agreements with China that were established in January 2020. Bessent’s comments came during an appearance on Fox Business, where he emphasized the need for China to de-escalate its tariffs.Bessent stated the US is committed to ensuring that China honors the agreements previously signed. H ...
By David Shepardson and Allison Lampert WASHINGTON (Reuters) - A senior U.S. lawmaker has warned Ryanair against purchasing Chinese-made aircraft due to security concerns, following comments by the CEO of the low-cost Irish airline that he would consider buying Chinese jets at the right price, according to a letter seen by Reuters. Ryanair responded to the letter by saying it would consider cancel ...